This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jurgen Vercruysse: Innovator in Veterinary Pharmaceuticals
Introduction
Jurgen Vercruysse is a notable inventor based in Zulte, Belgium. He has made significant contributions to the field of veterinary medicine, particularly in the development of pharmaceutical compositions for companion animals. His work focuses on improving the well-being of pets, addressing issues such as anxiety and fear during transportation and veterinary visits.
Latest Patents
Jurgen Vercruysse holds a patent for "Pregabalin formulations and use thereof." This invention relates to a pharmaceutical composition in the form of an orally deliverable liquid that includes pregabalin as an active ingredient. The composition is designed to treat and prevent anxiety and fear in companion animals, such as cats, during stressful situations. It is stable, palatable, and easy for pet owners to administer.
Career Highlights
Vercruysse is associated with Orion Corporation, where he continues to innovate in the field of veterinary pharmaceuticals. His work has been instrumental in developing solutions that enhance the quality of life for pets and their owners.
Collaborations
He has collaborated with notable colleagues, including Terttu Lamminen and Jukka Salmia, to advance research and development in veterinary medicine.
Conclusion
Jurgen Vercruysse's contributions to veterinary pharmaceuticals highlight his commitment to improving animal health and well-being. His innovative approach to addressing anxiety in pets showcases the importance of research in enhancing the human-animal bond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile